The Respiratory Syncytial Virus G Protein Conserved Domain Induces a Persistent and Protective Antibody Response in Rodents

Current progress on development of respiratory syncytial virus vaccine

(2011) Jun Chang   BMB Reports

A review of palivizumab and emerging therapies for respiratory syncytial virus

(2011) Kristin A Shadman et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Soluble Respiratory Syncytial Virus Fusion Protein in the Fully Cleaved, Pretriggered State Is Triggered by Exposure to Low-Molarity Buffer

(2011) S. Chaiwatpongsakorn et al.   JOURNAL OF VIROLOGY

Purification of human respiratory syncytial virus fusion glycoprotein

(2011) Yanpeng Zheng et al.   PROTEIN EXPRESSION AND PURIFICATION

RSV 2010: Recent advances in research on respiratory syncytial virus and other pneumoviruses

(2011) Grada M. van Bleek et al.   VACCINE

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

(2011) Peter L. Collins et al.   VIRUS RESEARCH

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

(2010) Barney S. Graham   IMMUNOLOGICAL REVIEWS

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naive and Formalin-Inactivated RSV-Immunized BALB/c Mice

(2010) G. U. Radu et al.   JOURNAL OF VIROLOGY

Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein

(2010) Yoshihiko Murata et al.   VACCINE

Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses

(2010) Guillermina A. Melendi et al.   VIRUS GENES

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

(2009) Lia M. Haynes et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice

(2009) W. Zhang et al.   JOURNAL OF VIROLOGY

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High‐Risk Elderly Individuals

(2008) Ann R. Falsey et al.   JOURNAL OF INFECTIOUS DISEASES

Respiratory syncytial virus (RSV) vaccines—Two steps back for one leap forward

(2007) Ultan F. Power   JOURNAL OF CLINICAL VIROLOGY

Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives

(2007) Raghavendra C. Mundargi et al.   JOURNAL OF CONTROLLED RELEASE